Conditioning Agent
SR-(HEXAPEPTIDE-40 OLIGOPEPTIDE-91 CLOSTRIDIUM BOTULINUM POLYPEPTIDE-1)
Safety score · 0–100
Moderate
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
A recombinant peptide complex marketed for skin-conditioning, but it sits in the low-evidence bioactive category.
This fusion peptide is produced by biotechnology and includes a botulinum-derived peptide segment, though it is not the same as botulinum toxin injection material. Cosmetic exposure is topical and typically low, but independent human safety and efficacy literature is thin compared with simpler ingredients. That uncertainty pulls the score down despite the absence of a clear regulatory ban in the provided data.
Function
Skin benefits
- May support skin-conditioning effects
- May help reduce the appearance of expression lines
Known concerns
- Very limited independent safety data
- Bioactive recombinant peptide
- Potential irritation on compromised skin
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related conditioning agents
Check your shelf
Find SR-(HEXAPEPTIDE-40 OLIGOPEPTIDE-91 CLOSTRIDIUM BOTULINUM POLYPEPTIDE-1) in your products.
Scan any cosmetic product with LuxSense to see if it contains SR-(HEXAPEPTIDE-40 OLIGOPEPTIDE-91 CLOSTRIDIUM BOTULINUM POLYPEPTIDE-1) and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.